CN1124155C - Medicine for treating leukoderma and preparing process - Google Patents
Medicine for treating leukoderma and preparing process Download PDFInfo
- Publication number
- CN1124155C CN1124155C CN 99101472 CN99101472A CN1124155C CN 1124155 C CN1124155 C CN 1124155C CN 99101472 CN99101472 CN 99101472 CN 99101472 A CN99101472 A CN 99101472A CN 1124155 C CN1124155 C CN 1124155C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- medicine
- rhizoma
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a new medicine for treating vitiligo, which uses angelica, astragalus root, prepared rehmannia root, white atractylodes rhizome, tuckahoe, american ginseng, fleece-flower root, grassleaved sweetflag rhizome, curcuma root, alkanna tinctoria, paris rhizome, chuanxiong rhizome, red sage root, glossy privet fruit, safflower, peach kernel, tribulus terrestris and licorice root as raw materials. The method comprises the following steps: washing medicine herbs; drying medicine herbs in the sun; crushing the medicine herbs into fine powder; sieving the fine powder through a mesh; blending the fine powder; preparing the fine powder into a pill by adding water; sterilizing and drying the pill; obtaining a finished product. The medicine for treating vitiligo has the advantages of activating blood circulation, dissipating blood stasis, nourishing the liver and kidney, moistening the lung, strengthening the spleen, dispelling wind and eliminating heat-fire. The total effective rate of the medicine is 98% through the curative effect observation of an example, so that the curative effect of the medicine is very obvious.
Description
The present invention relates to a kind of medicine for the treatment of leukoderma, is the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically, the invention still further relates to the preparation method of this medicine.
Leukoderma is a kind of difficult dermatosis of coagulating of posteriority metabolism of pigment obstacle, sickness rate about 1%, and men and women, old and young all can be taken place, and are higher with the teenager sickness rate.
Pathogenic factor: medically think relevant at present with following factors.
The one, the autoimmune function disorder produces antibody to the melanin system, causes melanocyte to destroy, perhaps immunologic function degression.The 2nd, the endocrine disturbance, the pituitary secretion melanocyte stimulates is controlled, and tryrosinase lacks.The 3rd, delayed ischemic neurological deficits, nerve not tip secretion chemokines destroy melanocyte, control the activity that melanin produced or disturbed cheese ammonia enzyme.The 4th, the metabolism of trace elements imbalance reduces as copper, zinc, ferrum plasma.The 5th, heredity domesticly is lower than abroad, is about 3.9～4.7%.The 6th, environmental pollution, harmful substance is to the influence of human body, as phenolate etc.
Leukoderma is ill to be thought in the traditional Chinese medical science: because the rheumatism heresy goes into fur, ailment said due to cold or exposure is attacked skin, disorder of QI and blood, skin losing its nutrition and due to.Usually be divided into four classes: wind and cold is damp and hot, deficiency of both the splenic and pulmonary QI, the hepatic and renal YIN deficiency, QI and blood and void.
Leukoderma is sent out in the exposure portion of being ground behaviour well, is common in head, face, cervical region, trunk, extremity, and macule mostly is white, and the form size puts down one, and isolated or symmetry distributes no conscious sympton, no infectiousness.Can be divided into four types by its site distribution and area size: general hair style, distribute type, topical type, dizzy nevus type, preceding amphitypy is relatively more obstinate.
In the leukoderma treatment, whole body therapeutic is used vitamin or hormones usually at present, and effect is relatively poor.Contain the hormone composition as Western medicine " BAILING PIAN ", side effect is arranged, should not take for a long time.And on market, do not have pure Chinese medicinal preparation can supply treatment leukoderma patient.
The object of the present invention is to provide a kind of strengthening the body resistance, adopt blood circulation promoting and blood stasis dispelling, nourishing the liver and kidney, lung moistening spleen invigorating, expelling wind and clearing away heat four ruling by law to treat the medicine of leukoderma.
Another object of the present invention provides the preparation method of this leukoderma medicine.
Solution of the present invention is a utilization motherland theory of medicine, in the cause of disease, pathogenesis, pathological classification, by stages, control agent, first Zhi Qiben, based on kidney, collateral dredging is invigorated blood circulation, detoxification and promoting urination, and wind dispelling is antipruritic, the QI invigorating speckle dispelling, the soothing liver-QI lung moistening, strengthening the spleen and stomach is transferred the painstaking effort function of living, and makes the growth of skin lesion melanin, disappear day shift, recovers the medicine of normal skin color.
Medicine of the present invention is made (consumption is a weight portion) by following component:
Radix Angelicae Sinensis 4-8 part Radix Astragali 6-9 part Radix Rehmanniae Preparata 3-7 part
Rhizoma Atractylodis Macrocephalae 4.5-8.5 part Poria 2-6 part Radix Panacis Quinquefolii 8-13 part
Radix Polygoni Multiflori 3-7 part Rhizoma Acori Graminei 2-6 part Radix Curcumae 2-6 part
Radix Arnebiae (Radix Lithospermi) 5-9 part Rhizoma Paridis 2-6 part Rhizoma Chuanxiong 2-6 part
Radix Salviae Miltiorrhizae 2-6 part Fructus Ligustri Lucidi 2-6 part Flos Carthami 2-5 part
Semen Persicae 2-5 part Fructus Atriplicis Sibiricae 8-13 part Radix Glycyrrhizae 2-5 part
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Radix Angelicae Sinensis 5-7 part Radix Astragali 6-8 part Radix Rehmanniae Preparata 4-6 part
Rhizoma Atractylodis Macrocephalae 5-8 part Poria 3-5 part Radix Panacis Quinquefolii 9-12 part
Radix Polygoni Multiflori 4-6 part Rhizoma Acori Graminei 3-5 part Radix Curcumae 3-5 part
Radix Arnebiae (Radix Lithospermi) 6-8 part Rhizoma Paridis 3-5 part Rhizoma Chuanxiong 3-5 part
Radix Salviae Miltiorrhizae 3-5 part Fructus Ligustri Lucidi 3-5 part Flos Carthami 3-4 part
Semen Persicae 3-4 part Fructus Atriplicis Sibiricae 9-12 part Radix Glycyrrhizae 3-4 part
The optimum weight proportioning of medicine of the present invention is:
5.4 parts of 7.2 parts of Radix Rehmanniae Preparata of 5.8 parts of Radixs Astragali of Radix Angelicae Sinensis
10.8 parts of 4.3 parts of Radix Panacis Quinquefoliis of 6.5 parts of Poria of the Rhizoma Atractylodis Macrocephalae
4.3 parts of 4.3 portions of Radix Curcumaes of 5.4 parts of Rhizoma Acori Graminei of Radix Polygoni Multiflori
4.3 parts of 4.3 parts of Rhizoma Chuanxiongs of 7.2 parts of Rhizoma Paridis of Radix Arnebiae (Radix Lithospermi)
3.6 parts on 4.3 parts of Flos Carthamis of 4.3 parts of Fructus Ligustri Lucidi of Radix Salviae Miltiorrhizae
3.6 parts in 10.8 portions of Radix Glycyrrhizaes of 3.6 parts of Fructus Atriplicis Sibiricaees of Semen Persicae
The present invention treats the medicine of leukoderma, and its said medicament is pill or piece agent or powder.
Above-mentioned each component is made medicine production method of the present invention is:
Get each raw material and clean respectively, dry, be broken into fine powder, cross 80 mesh standard sieves, mixing, water pill, sterilization, drying, packing, finished product.
In the medicine material of the present invention, Radix Panacis Quinquefolii, the Radix Astragali, Poria, the Rhizoma Atractylodis Macrocephalae are for setting upright the medicine that fills blood, can promote the human lymphocyte transformation function,, reach the function of interior humoral immunization of enhancing body and cellular immunization as having share the enhancing macrophage phagocytic function with Poria, the Rhizoma Atractylodis Macrocephalae; Radix Polygoni Multiflori, Fructus Ligustri Lucidi, Radix Glycyrrhizae are the nourishing liver and kidney medicine, add the medicine of replenishing the calcium of invigorating blood circulation, and both have share mutual promoting action Radix Salviae Miltiorrhizae, Rhizoma Paridis, Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Arnebiae (Radix Lithospermi); Fructus Atriplicis Sibiricae, Radix Curcumae, Rhizoma Acori Graminei are the medicine that dispels the wind, and and restart promoting blood circulation by removing wind, the effect of depressed liver-energy dispersing and QI regulating.
Medicine of the present invention is through 414 routine leukoderma treatments, and criterion of therapeutical effect: complete: treatment took a turn for the better in 2-6 month, and 1 year complete, and skin lesion melanin is grown fully, and white macula all disappears, and recovers the normal skin color.Effectively: treatment 2-6 month is the growth of part melanin, but does not surpass 40% that white macula stops morbidity.Invalid: be local white macula no change, white macula continues diffusion and increases.
The present invention's 414 routine treatment targets: male's 202 examples, women's 212 examples, 3 years old to 59 years old age, the course of disease 1 month to 35 years, workman 116 people, peasant 46 people, cadre 66 people, commercial 16 people, student 130 people, teacher 6 people, soldier 10 people, child 24 people.
Therapeutic outcome: leukoderma 414 examples, 268 examples that heal entirely, effective 134 examples, invalid 2 examples, total effective rate 98% is treated effective patient, is treating 2 months with the interior pigment that occurs mostly, the patient that the course of disease is short, curative effect is better relatively, and period in a medicine is not seen other side effect.
The present invention prepares embodiment:
Take by weighing raw material by following proportioning:
The Radix Angelicae Sinensis 580 gram Radixs Astragali 720 gram Radix Rehmanniae Preparata 540 gram Rhizoma Atractylodis Macrocephalaes 650 grams
Poria 430 gram Radix Panacis Quinquefoliis 1080 gram Radix Polygoni Multiflori 540 gram Rhizoma Acori Graminei 430 grams
Radix Curcumae 430 gram Radix Arnebiae (Radix Lithospermi)s the 720th grammes per square metre buildings 430 gram Rhizoma Chuanxiongs, 430 grams
Radix Salviae Miltiorrhizae 430 gram Fructus Ligustri Lucidi 430 gram Flos Carthamis 360 gram Semen Persicaes 360 grams
Fructus Atriplicis Sibiricae 1080 gram Radix Glycyrrhizaes 360 grams
Production method is as follows:
Get each raw medicinal material respectively and clean, dry, be broken into fine powder, cross 80 mesh standard sieves, advance Drug Manufacturing Room and produce (cleaning shop, ten thousand grades of inside and outside preparations), mixing, water pill (water pill is placed on the sterile chamber) was sterilized drying, packing, finished product 45 minutes for ten thousand grades.Be named the speckle removing ball of complying with one's wishes.Adopt pure Chinese medicine preparation, every bottle 36 gram, every day three times, each 6 grams take with boiled water.
Claims (5)
1, a kind of medicine for the treatment of leukoderma is characterized in that it is the medicament of being made by the following weight proportion raw material
Radix Angelicae Sinensis 4-8 part Radix Astragali 6-9 part Radix Rehmanniae Preparata 3-7 part
Rhizoma Atractylodis Macrocephalae 4.5-8.5 part Poria 2-6 part Radix Panacis Quinquefolii 8-13 part
Radix Polygoni Multiflori 3-7 part Rhizoma Acori Graminei 2-6 part Radix Curcumae 2-6 part
Radix Arnebiae (Radix Lithospermi) 5-9 part Rhizoma Paridis 2-6 part Rhizoma Chuanxiong 2-6 part
Radix Salviae Miltiorrhizae 2-6 part Fructus Ligustri Lucidi 2-6 part Flos Carthami 2-5 part
Semen Persicae 2-5 part Fructus Atriplicis Sibiricae 8-13 part Radix Glycyrrhizae 2-5 part.
2, the medicine of treatment leukoderma as claimed in claim 1, wherein the weight proportion of each raw material is:
Radix Angelicae Sinensis 5-7 part Radix Astragali 6-8 part Radix Rehmanniae Preparata 4-6 part
Rhizoma Atractylodis Macrocephalae 5-8 part Poria 3-5 part Radix Panacis Quinquefolii 9-12 part
Radix Polygoni Multiflori 4-6 part Rhizoma Acori Graminei 3-5 part Radix Curcumae 3-5 part
Radix Arnebiae (Radix Lithospermi) 6-8 part Rhizoma Paridis 3-5 part Rhizoma Chuanxiong 3-5 part
Radix Salviae Miltiorrhizae 3-5 part Fructus Ligustri Lucidi 3-5 part Flos Carthami 3-4 part
Semen Persicae 3-4 part Fructus Atriplicis Sibiricae 9-12 part Radix Glycyrrhizae 3-4 part.
3, the medicine of treatment leukoderma as claimed in claim 1, wherein the weight proportion of each raw material is:
5.4 parts of 7.2 parts of Radix Rehmanniae Preparata of 5.8 parts of Radixs Astragali of Radix Angelicae Sinensis
10.8 parts of 4.3 parts of Radix Panacis Quinquefoliis of 6.5 parts of Poria of the Rhizoma Atractylodis Macrocephalae
4.3 parts of 4.3 portions of Radix Curcumaes of 5.4 parts of Rhizoma Acori Graminei of Radix Polygoni Multiflori
4.3 parts of 4.3 parts of Rhizoma Chuanxiongs of 7.2 parts of Rhizoma Paridis of Radix Arnebiae (Radix Lithospermi)
3.6 parts on 4.3 parts of Flos Carthamis of 4.3 parts of Fructus Ligustri Lucidi of Radix Salviae Miltiorrhizae
3.6 parts in 10.8 portions of Radix Glycyrrhizaes of 3.6 parts of Fructus Atriplicis Sibiricaees of Semen Persicae.
4,, it is characterized in that said medicament is pill or piece agent or powder as the medicine of claim 1 or 2 or 3 described treatment leukodermas.
5, the preparation method of the medicine of treatment leukoderma as claimed in claim 4 is characterized in that getting each raw material and cleans respectively, dries, and is broken into fine powder, crosses 80 mesh standard sieves, mixing, water pill, sterilization, dry, packing, finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99101472 CN1124155C (en) | 1999-02-26 | 1999-02-26 | Medicine for treating leukoderma and preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99101472 CN1124155C (en) | 1999-02-26 | 1999-02-26 | Medicine for treating leukoderma and preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1264589A CN1264589A (en) | 2000-08-30 |
| CN1124155C true CN1124155C (en) | 2003-10-15 |
Family
ID=5270460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99101472 Expired - Fee Related CN1124155C (en) | 1999-02-26 | 1999-02-26 | Medicine for treating leukoderma and preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1124155C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177246A (en) * | 2016-08-26 | 2016-12-07 | 张绪伟 | Treat leukodermic compound ointment |
| CN107485649A (en) * | 2017-09-05 | 2017-12-19 | 李太平 | A kind of formula for treating leucoderma and preparation method thereof |
-
1999
- 1999-02-26 CN CN 99101472 patent/CN1124155C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1264589A (en) | 2000-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100536885C (en) | Medicine for treating phalacrosis and restoring hair | |
| CN101703730B (en) | Health care wine made of ginseng and the like | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN101732683A (en) | Chinese medicinal preparation for treating facial chloasma and preparation method thereof | |
| CN101380386A (en) | Traditional Chinese medicine composition for tonifying the kidney yang | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
| CN1814121A (en) | Medicine for treating protrusion of intervetebral disc and cervical vertebra disease | |
| CN105126045A (en) | Traditional Chinese medicinal composition for treating climacteric syndrome | |
| CN1049827C (en) | Anti-cancer powder | |
| CN101239134B (en) | Speckle-removing medicinal composition | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN1124155C (en) | Medicine for treating leukoderma and preparing process | |
| CN1170553C (en) | Medicinal wine for treating rheumatic and rheumatoid diseases and its preparing prcess | |
| CN101322775A (en) | Chinese medicine for treating psoriasis | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN1232290C (en) | Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis | |
| CN1500513A (en) | Instant traditional Chinese medicine formulation for headache | |
| CN102451458A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN105998582A (en) | Preparation method of traditional Chinese medicinal composition for treating rheumatoid arthritis | |
| CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN105617012A (en) | Traditional Chinese medicine composition for treating constipation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |